Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
1.680
+0.050 (3.07%)
At close: Oct 22, 2024, 4:00 PM
1.670
-0.010 (-0.60%)
After-hours: Oct 22, 2024, 7:59 PM EDT

Virax Biolabs Group Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Oct '24 Mar '24 Mar '23 Mar '22 Mar '21 Mar '20
Market Capitalization
7211---
Market Cap Growth
-84.34%-84.34%----
Enterprise Value
4-46---
Last Close Price
1.680.726.95---
PE Ratio
--0.21-1.35---
PS Ratio
21.5510.831262.87---
PB Ratio
0.810.331.21---
P/FCF Ratio
-0.24-0.24-2.59---
P/OCF Ratio
-0.27-0.27-2.59---
EV/Sales Ratio
23.17-22.74701.38---
EV/EBITDA Ratio
0.590.59----
EV/EBIT Ratio
0.580.58-1.05---
EV/FCF Ratio
0.490.49-1.44---
Debt / Equity Ratio
0.040.040.02--0.21-0.62
Debt / FCF Ratio
-0.03-0.03-0.04--0.30-1.01
Asset Turnover
0.020.020.00-3.98-
Inventory Turnover
0.640.640.44---
Quick Ratio
23.0123.0110.350.020.020.02
Current Ratio
25.9425.9410.610.040.050.02
Return on Equity (ROE)
-95.98%-95.98%-141.63%---
Return on Assets (ROA)
-49.90%-49.90%-72.67%-2453.52%-1294.67%-
Return on Capital (ROIC)
-52.89%-52.89%-91.03%---
Earnings Yield
-92.31%-397.61%-50.48%---
FCF Yield
-98.70%-425.13%-38.66%---
Buyback Yield / Dilution
-88.75%-88.75%-11.15%-297.67%-130.43%-
Total Shareholder Return
-88.75%-88.75%-11.15%-297.67%-130.43%-
Source: S&P Capital IQ. Standard template. Financial Sources.